Bone regeneration by basic fibroblast growth factor complexed with biodegradable hydrogels.
The objective of this study is to enhance the bone induction activity of basic fibroblast growth factor (bFGF) for reconstruction of skull bone defects which has been clinically recognized as almost impossible. For this purpose, we prepared biodegradable hydrogels from gelatin with an isoelectric point of 4.9 which is capable of polyionic complexing with basic bFGF. When implanted in rabbit skull defects of 6 mm in diameter (6 defects per experimental group), the gelatin hydrogels incorporating 100 microg of bFGF promoted bone regeneration at the defect in marked contrast to free bFGF of the same dose, finally closing the bone defects after 12 weeks of implantation as is apparent from histological examination. In dual energy X-ray absorptometry analysis, the bone mineral density at the skull defects enhanced by the hydrogels was significantly higher than that by free bFGF at doses ranging from 2 to 200 microg/defect (P < 0.05). The extent of bone regeneration induced by gelatin hydrogels incorporating 100 microg of bFGF increased with a decrease in their water content. Histological examination indicated that more slowly degrading hydrogels of lower water content prolonged the retention period of osteoblasts in the bone defects. This led to enhanced bone regeneration compared with faster degrading hydrogels of higher water content. It was concluded that this biodegradable hydrogel system was a promising surgical tool to assist self-reconstruction of the skull bone.
Tabata
Y
Y
Research Center for Biomedical Engineering, Kyoto University, Japan.
Yamada
K
K
Miyamoto
S
S
Nagata
I
I
Kikuchi
H
H
Aoyama
I
I
Tamura
M
M
Ikada
Y
Y
D000818:Animals; D001711:Biotransformation; D001861:Bone Regeneration / Q000187:drug effects*; D002113:Calcification, Physiologic / Q000187:drug effects; D016222:Fibroblast Growth Factor 2 / Q000008:administration & dosage* / Q000737:chemistry; D005780:Gelatin / Q000008:administration & dosage / Q000737:chemistry; D006859:Hydrogen / Q000008:administration & dosage* / Q000737:chemistry; D007526:Isoelectric Point; D010006:Osteoblasts / Q000166:cytology / Q000187:drug effects; D019736:Prostheses and Implants; D011817:Rabbits; D012886:Skull / Q000166:cytology / Q000187:drug effects / Q000502:physiology
D016222:Fibroblast Growth Factor 2; D006859:Hydrogen; D005780:Gelatin